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Background: Patient-centered care is a hallmark of quality in healthcare. It is
defined as care that is respectful of, and responsive to, individual patient preferences, needs, and values, while ensuring patients are informed and engaged in the
treatment decision-making process.
Methods: We reviewed the literature and drew upon our own experiences to study
the implementation of tools intended to facilitate shared decision-making in breast
reconstruction.
Results: For women with breast cancer, decision-making about breast reconstruction is often a challenging and perplexing process. The variety of choices available regarding timing and type of reconstruction and the unique individual patient
and clinical treatment variables to consider can further complicate decisions.
Accordingly, strategies to facilitate the decision-making process and enable patients
and clinicians to make high-quality decisions about breast reconstruction are an
essential component of comprehensive breast cancer care. Shared decision making is one proposed model to support informed and preference-sensitive decisionmaking in line with the principles of patient-centered care. Despite an emerging
level of interest in shared decision making, there remains a lack of clarity regarding
what the process involves and how to effectively implement it into clinical practice.
Conclusions: Thus, widespread adoption of shared decision making remains lacking in clinical practice for women considering postmastectomy breast reconstruction. To address these gaps, this article reviews the principles of shared decision
making, explores ways shared decision making can be utilized for patients who are
candidates for breast reconstruction, and provides a practical overview to facilitate
implementation of shared decision making into clinical practice. (Plast Reconstr
Surg Glob Open 2020;8:e2645; doi: 10.1097/GOX.0000000000002645; Published online
6 February 2020.)

INTRODUCTION

A 52-year-old woman presents with a new, left 2.0-cm
invasive ductal carcinoma. She has a history of left ductal carcinoma in situ treated with breast conservation
therapy. Her breast remains indurated with predominantly superomedial volume loss, nipple-areolar distortion, and malposition. The new breast cancer is located
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in the inferolateral quadrant. The left breast is estimated
to weigh ~800 g and the right ~1,000 g. The patient is a
nonsmoker, has a body mass index (BMI, kg/m2) of 32,
travels 3 hours each way to see her plastic surgeon, and
has had a laparotomy and left lower quadrant colostomy
from a traumatic injury. Her surgical oncologist has recommended bilateral mastectomies. The patient requests
immediate prepectoral implants following nipple-sparing mastectomy based on a friend’s experience. You are
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running behind in clinic this afternoon and still have 6
other new patients to see in the next 2 hours.

THE ROLE OF SHARED DECISION-MAKING
IN BREAST RECONSTRUCTION

Patients, physicians, administrators, insurance companies, and policy makers are committed to supporting
high-quality postmastectomy breast reconstruction that
produces favorable outcomes with minimal complications. These individuals recognize the importance of these
goals overall, but may differ in how they are prioritized.
Shared decision-making (SDM) engages women and their
plastic surgeons to consider whether, when, and how to
reconstruct the breast following mastectomy. Patient decision aids (DAs) can provide a framework that supports
the SDM process for women considering the option of
postmastectomy breast reconstruction.1–5 In theory, SDM,
is a necessary component of the preoperative interaction
between plastic surgeons and their patients considering
reconstruction. Indeed, many plastic surgeons report that
they already engage in an SDM process, in spirit, if not by
name. In practice, however, several barriers can derail a
well-intentioned plastic surgeon from engaging in effective SDM.
In the case example above, immediate reconstruction, elevated BMI, and former radiation are all associated
with increased reconstructive failure rates. Immediate,
implant-based reconstruction is particularly problematic
in the setting of radiation and obesity.6 Application of
an evidence-based approach to this case favors delayed
reconstruction following skin-sparing mastectomy with
autologous flaps. Her previous history of abdominal
surgery requires thigh-, buttock-, latissimus-, or lumbarbased autologous flap options. These strategies stand in
contrast, however, with the patient’s initial preference for
direct-to-implant reconstruction immediately following
nipple-sparing mastectomy.
SDM is ideally suited to this clinical situation. Although
the outcomes of each reconstruction option might not be
completely equivalent given the patient’s history and clinical characteristics, several treatment choices are available
to this patient. This patient may not fully understand the
pros and cons of each option. Engaging the patient in
a review of treatment options while exploring her preferences can help the surgeon and patient arrive at an
informed, preference-concordant decision. Ultimately,
the patient’s individual risk factors and clinical characteristics will need to be balanced with her preferences and
goals to make a high-quality treatment decision.
Table 1. SHARE Approach to SDM*
Step

Description

1
2
3
4
5

Seek patient’s participation
Help patient explore and compare treatment options
Assess patient values and preferences
Reach a decision with the patient
Evaluate patient’s decision

*The Agency for Healthcare Research and Quality SHARE Approach to SDM.9

2

FIVE STEPS OF SDM

The Agency for Healthcare Research and Quality proposes the “SHARE” Approach to SDM based on 5 essential
steps (Tables 1 and 2).7,8 These steps can be tailored to
suit a particular patient encounter and represent a practical and efficient way to engage patients in SDM. Most
patients prefer a collaborative approach over deferring
treatment decisions to their clinician.12–14 In many cases,
however, patients are aware of a power differential in the
patient–physician relationship and may be reticent to
initiate a 2-way conversation regarding breast reconstruction.15 For this reason, the plastic surgeon should begin
the SDM process. For example, the surgeon can state “It is
helpful for you to share what is important to you so we can
make the best treatment together.” In the second stage
of SDM, plastic surgeons describe reconstructive treatment options and each option’s pros and cons. The third
step of SDM involves assessing patients’ preferences and
prioritizing and contextualizing those preferences in the
setting of breast reconstruction. For example, the relative
importance of breast aesthetics or the degree to which a
women’s perceived identity is defined by them, fear of surgery or the medical community in general, socioeconomic
concerns, impact on occupation or family, and travel distance can impact a patient’s approach to decision-making.
The relative merits of available reconstruction options are
then juxtaposed with an individual patient’s preferences
to reach a decision in the fourth step of SDM. The fifth
and final step of Agency for Healthcare Research and
Quality’s SHARE approach is to consider next steps that
facilitate implementing the decision. For breast reconstruction, this can involve coordinating with the surgical
and potential medical and radiation oncology providers.
Furthermore, it may involve giving patients the appropriate amount of time to consider their options, discuss
with family/friends/other patients, and weigh any social
and economic influences on the decision (ie, support at
home, time off work, etc.).

CHALLENGES AND SOLUTIONS FOR
IMPLEMENTING SDM

Although an SDM approach to breast reconstruction is
favored by most plastic surgeons in theory, several barriers
can limit its implementation in practice.
Finding Time to Engage in SDM

Foremost among the barriers to SDM is allotting
adequate time to the SDM process: (1) time to explore
reconstructive options and to make sure that patients
understand the discussion; (2) time to understand a
patient’s preferences; (3) time to review information or
a patient’s initial thoughts in the face of a condensed
runway from consultation to surgery, an advanced tumor
that mandates rapid intervention, and busy schedules.
We have previously shown that implementation of a highquality DA before a face-to-face visit can improve breast
reconstruction quality by reducing knowledge gaps without prolonging length of visit.16 Patients can use a DA at
home, where there can be more time and family support
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Table 2. Challenges and Solutions with the SHARE Approach to SDM
Challenge
Patient reticent to engage in SDM.

Patient having difficulty understanding
treatment options.
Patient is clinically a reasonable candidate for
both autologous and implant options, but is
having a hard time deciding between them.
Despite the physician engaging the patient
in SDM, exploring treatment options, and
learning their preferences, the patient
remains reluctant to make a decision about
type of reconstruction.
Socioeconomic barriers including perceived
time off work and anticipated out-of-pocket
costs are a primary driver of the patient’s
decision-making.
The patient wants the surgeon to decide how
to proceed.
A patient with numerous major risk factors
for complications (eg, smoking, obesity,
diabetes, COPD) advocates for immediate
implant breast reconstruction despite
strong evidence to suggest she is at risk for
complications.

Solution
Identify reasons for reluctance such as lack of awareness of SDM or power dynamics. Involve
patient in SDM to the degree they are comfortable. Ask patients about their preferences
and check to make sure the treatment plan aligns with those preferences, even if the
patient desires less engagement. Example language: “Every patient has different goals,
and there is more than one choice of surgery. I want to make sure the surgery plan we
choose is consistent with your goals of care.”
Reduce the use of jargon. Create or obtain DAs and educational materials with an accessible
reading level. When language is a barrier, use a translator to aid the discussion. Consider
using pictures or photographs.
Use a DA to help review patient preferences and goals. Specific concerns include time
off work, number of surgeries, aesthetic outcome, concerns about implants, flap donor
sites, or social and economic circumstances (eg, travel distance, family or job stressors).
Incorporate these aspects into the discussion.
Confirm that the patient is comfortable with their decisions leading up to the type of
reconstruction (ie, mastectomy versus BCT versus screening imaging for prophylactic
cases, or immediate versus delayed timing). Provide the patient a written summary of the
SDM discussion. Ask them to make a second appointment before which they can consider
their options.
Inform the patient of when you anticipate that they can resume their day-to-day functions
independently and get back to work. Provide referrals for financial resources to enable
them to learn what their insurance deductible payments will be in advance. Provide
information regarding financial assistance available through hospital- and communitybased charities.10,11 Resources to provide insurance coverage, help pay deductibles, cover
medication costs, assist with travel or provide physical therapy may be available.11
Make a recommendation that is based on your understanding of the patient’s preferences to
the extent that it is congruent with their risk profile. Outline how the recommendation is
based on their characteristics and preferences so they may weigh in.
This patient is at high risk for complications regardless of chosen reconstructive technique.
Delayed reconstruction and use of an autologous flap in a radiated field are both
strategies strongly supported by evidence, and personalized risk communication might
facilitate an evidence-informed choice. In addition to delaying the reconstruction, help
the patient with weight loss, smoking cessation, and/or blood sugar regulation, with set
goals and follow-up appointments to discuss this plan and barriers to it. Consider referral
to another plastic surgeon to reinforce the safest reconstructive approach.

BCT, breast conservation therapy; COPD, chronic obstructive pulmonary disease.

to review new, complex information, or in a waiting room
or clinic room before the start of a consultation for those
without Internet access or those preferring to review the
information on-site. For the surgeon, this patient can be
better prepared with evidence-based information and
some initially formed preferences before the conversation
with the surgeon. Alternatively, a DA can be used to reinforce physician–patient communication and potentially
diffuse a time-pressured interaction by administering it in
the postconsultation phase.17 Next, it is imperative that the
plastic surgeons spend adequate time with their patients
to develop trust and ensure that they have a handle on the
medical and social variables that may impact breast reconstruction. Instructional videos as used in some patient
education materials,18 initial discussions with an experienced nurse, nurse practitioner, or PA, and informational
brochures can supplement the plastic surgery clinic experience and provide support using an interprofessional
team-based approach to SDM.19
Quality of Information That Supports SDM

The information plastic surgeons use to define various reconstructive options may also represent a barrier
to SDM. The quality and level of evidence to describe
clinical and patient-reported outcomes has improved,
but continues to have limitations. A DA can implement
risk prediction into the SDM process to address some of

these evidence limitations. As an example, a DA we previously developed and evaluated, the Breast Reconstruction
Education and Support Tool (BREASTChoice), combines
a risk prediction model derived from analysis of 17,000
patients undergoing surgical treatment for breast cancer
and uses clear, standardized visual tools to communicate
risk.20 Reported risks are derived from a wide breadth of
providers, patients, and care settings to improve their generalizability. By inserting evidence-based clear risk prediction into the SDM process, consistent information can be
communicated to patients. Regardless of the exact construct of the DA, incorporation of a risk prediction model
that accounts for patient’s clinical characteristics (eg,
BMI, smoking status, hypertension, lung disease, previous
radiation therapy, diabetes, medications) and communicates it clearly can improve patient understanding of the
likelihood of complications with reconstruction options.
Of equal importance is the availability of information
that a particular patient perceives as relevant to them. The
Surveillance, Epidemiology, and End Results database has
been effectively leveraged to identify barriers to reconstruction including overall access and availability of information, most prominently for women from racial and
socioeconomically marginalized groups.21–23 Indeed, we
have noted that women often perceive race- or age-related
biases with information sharing.13 Patient materials need
to include images that represent the breadth of skin tones,
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BMIs, and ages of women who seek breast reconstruction.13,16 Breast reconstruction studies that have emerged
to address quality of life, unique preferences and needs
of potentially marginalized communities, and factors such
as social support, time to heal, and travel distance can be
extremely important for patients.24
Quality of Communication between Plastic Surgeons and
Their Patients

How plastic surgeons and patients communicate with
each other significantly impacts SDM and can be influenced by dynamics of the doctor–patient relationship.
This will vary from 1 case to the next, influenced by variables such as race, socioeconomic status, religion, health
literacy and numeracy, age, and the length of the patient–
clinician relationship. The plastic surgeon must be aware
of his/her own biases and the perception of a power
imbalance that a patient may have when interacting with
their surgeon. These factors impact the physician–patient
interaction, possibly impeding a patient’s willingness or
confidence to openly communicate her values and preferences. Fortunately, several strategies can be employed
to optimize communication. First, the plastic surgeon
must recognize that barriers to communication may exist
and not make assumptions about whether this is the case
based on a particular patient’s profile. The plastic surgeon
can ask open-ended questions and avoid medical jargon.
Information exchange between patients and their plastic surgeons can occur despite potential barriers to communication with the implementation of a clinical DA. To
broaden the generalizability of a DA, it is critical that they
be written with broadly accessible language; standards suggest a seventh-grade reading level or below.25 The plastic
surgeon can modulate the level of complexity discussed
thereafter, taking great care to be understandable on
the one hand, but not condescending on the other. Data
regarding risks can be presented as percentages and proportions to facilitate patient understanding and the surgeon can seek to confirm a patient’s understanding using
the teach-back technique (“tell me your understanding
of what we just talked about”). All of these strategies are
aimed at improving physician–patient communication.
Precision of Medical Information Used to Predict Risk

The quality of research that generates the data used
to inform risk prediction algorithms with postmastectomy
breast reconstruction is critically important. However,
these algorithms are only accurate if complete and accurate data for a particular patient are entered. Incomplete
or inaccurate data can generate false assessments of risk
prediction that can have more negative repercussions
than using no risk prediction model at all. Manual data
entry is an option, but this can be both resource and time
intensive, and a clear barrier to broad adoption of a clinical DA. One solution is to auto-populate the risk prediction model algorithm through customized programming
of the electronic medical record. This approach also
serves to integrate the clinical DA into the patient medical
record and can serve to provide a dynamic risk assessment
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as a patient’s circumstances change (ie, quit smoking, lost
weight, now require radiation therapy).
A Fluid Approach to Accommodate Evolving Oncologic Care
and Complications

Critical pieces of information that may impact decision-making for reconstructing a newly diagnosed breast
cancer are often unavailable when a patient first meets
their plastic surgeon. Information on margins, tumors
markers, lymph node status, distant metastases, additional
imaging, and genomic and genetic testing is usually pending but can have profound impact on the overall multidisciplinary management strategy. Occasionally, the plastic
surgeon is required to react to circumstances not necessarily anticipated during the initial consultation and alter the
reconstruction conversation. For example, reexcision of
the skin envelope due to positive margins may expose the
originally placed immediate implant and mandate conversion to tissue expander or an autologous flap. It is critical that the surgical oncologist be included in decisions
throughout the SDM process. Complications that develop
over time will also affect, sometimes dramatically, the
initially prescribed treatment strategy. Optimizing strategies to treat and prevent the recurrence of breast cancer
will always be the priority. This dynamic process requires
a fluid and flexible approach to SDM. For example, an
implant-based reconstruction may have been favored by
the patient and a reasonable option based on risk assessment at the outset; however, a compromised skin envelope
due to an unforeseen explantation or unexpected need
for radiotherapy will typically trigger a change of plan,
whereby the autologous flap is now the favored option.
Discussing this openly with the patient so she can prepare
for possible outcomes is paramount to the SDM process
and a patient-centered approach to care.
Ideally, the concept of reconstruction is introduced by
the breast surgeon/surgical oncologist who needs to have a
working understanding of the procedures, their risks, and
how these are scheduled around other oncologic interventions. A surgical oncologist sensitive to the evidence that
favors 1 reconstruction over another based on factors such
as stage, likelihood or radiation, and breast size may preemptively refer the patient to a plastic surgeon capable
of offering the most clinically appropriate options. In our
practice, we have engaged in SDM and administered our
DA between the surgical oncology and plastic surgery visits.
However, we have encountered rare circumstances where
the plastic surgeon is seen before the surgical oncologist.
This most commonly occurs when a patient has had their
original workup and made the decision to have a mastectomy with 1 oncologist, but then has sought a second
opinion at our institution. To expedite scheduling and
intervention, the plastic surgeon may be seen before the
surgical oncologist. As such, not only the clinical circumstances that inform it but also the timing of its implementation needs to be fluid and adaptable in the SDM process.
To accommodate the dynamic breast reconstruction cycle of care, a malleable approach to SDM that is
responsive to evolving circumstances and relevant patient
data is required. As such, plastic surgeons need to remain
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committed to the SDM process through all of their patient
interactions. They need to have the expertise and knowledge to recognize what procedures best suit a particular patient at a given time and have the ability to offer
a breadth of reconstructive options that, based on available evidence, would be most appropriate for the patient.
If unable to offer a particular indicated procedure, they
must have the insight to refer the patient on to a plastic
surgeon who does offer a particular indicated procedure
for the good of the patient. Engagement in SDM throughout the course of breast reconstruction requires patience,
tenacity, time, insight, technical expertise, and wisdom.
SDM and Scope of Practice

Several practical considerations may temper a plastic
surgeon’s enthusiasm for engaging in SDM or using a DA.
One practical consideration is that some plastic surgeons
may not offer all available reconstructive techniques. For
example, not all plastic surgeons offer autologous flap
reconstructions that involve microsurgery and not all
plastic surgeons offer prepectoral breast reconstruction
techniques despite increasing evidence to support this
approach.26–28 A surgeon may be reluctant to engage in a
SDM process, or utilize a DA, that they are aware is likely to
suggest a particular procedure that they do not offer. This
reluctance may be borne of several factors. A plastic surgeon
may not have received training with a particular technique
or performs it so infrequently that they are uncomfortable
with it. Furthermore, the expenditure of resources required
to perform some techniques in particular may not be warranted in other practices whose infrastructure focuses on
the performance of other types of procedures. In some
health-care systems, access to the operating room is limited
and may deter plastic surgeons from offering microvascular breast reconstructions and encourage them to offer
reconstructive procedures that take less time to perform
or that can be more expeditiously scheduled to accommodate immediate postmastectomy breast reconstruction.
Similarly, institutional or system-based factors may penalize
or discourage providers from utilizing an acellular dermal
matrix in breast reconstruction (a key component of prepectoral reconstruction techniques).
There are several strategies that can improve the generalizability of the SDM process and DA tools in breast
reconstruction for all plastic surgeons who offer breast
reconstruction. In most cases, there are several reasonable
options for reconstructing a breast following mastectomy.
It is critical that the SDM process and accompanying decision support tools include all of these options so long as
they can be supported by evidence. By expanding the
scope of reasonable reconstructive options for a particular patient, the SDM approach becomes accessible to a
broader cohort of practitioners. As plastic surgeons, we
cannot dismiss both the science and art of our specialty.
The success of a reconstruction can vary based on subtle
nuances of technique and approach, derived from years of
a surgeon’s experience, that are not identified by analysis
of large datasets. The value of evidence-based medicine
cannot be denied, but neither should the value of a particular plastic surgeon’s experience.

In some cases, patients will be confronted with very few
reasonable reconstructive options. Under these circumstances, it is imperative that the plastic surgeon be able
to identify these cases and counsel patients appropriately.
The SDM process retains value in these cases as it can support a difficult decision to perform a potentially involved
surgical procedure or justify referral to another plastic surgeon specialist. Barriers to referral from 1 plastic surgeon
to another need to be overcome to ensure full engagement
in the SDM process and minimize delays in treatment or
performance of unnecessary procedures that are unlikely
to work. A plastic surgeon who does not commonly perform microsurgery, for example, may refer their patient
for a stacked perforator flap to a surgeon proficient in
these techniques. At the same time, a complex postreconstructive asymmetry in a patient who has voiced some dissatisfaction with their outcome may be best served with a
referral to another plastic surgeon experienced in breast
reconstruction to reinforce the complexities of a particular
patient’s circumstances, limitations of available corrective
techniques, and to provide a second opinion on what are
realistic expectations. The referring plastic surgeon needs
to feel comfortable that they can send their patient, with
whom they have developed a trusting relationship, to someone who will continue to provide the compassionate care
that has been provided to that point. The accepting plastic
surgeon needs to make time to see these referrals, commend the referring plastic surgeon for making decisions
that most benefit the patient, and refer the patient back
to the original plastic surgeon for additional procedures if
this is the preference of the referring plastic surgeon.
Ensuring that the breadth of breast reconstructive
options is available to patients in the future also depends
on the quality of breast reconstruction education offered
by residency training programs. Most plastic surgeons will
perform at least some breast reconstruction during their
careers and the vast majority will not do fellowship training in breast reconstruction. Plastic surgeons who can
confidently offer the breadth of breast reconstruction
options either themselves, or via a partner, are more likely
to engage in the SDM process.

CONCLUSIONS

SDM is an essential part of patient-centered care for
women with breast cancer. In this article, we reviewed the
principles of SDM and delineated the challenges, and
potential solutions to these challenges, of implementing
the SDM process into routine clinical care. As we strive to
improve the quality of care provided to women pursuing
breast reconstruction, it is our hope that the strategies outlined herein provide a practical guideline for plastic surgeons aiming to implement SDM in their clinical practices.
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